These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 27989690

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Correlation between right ventricular indices and clinical improvement in epoprostenol treated pulmonary hypertension patients.
    Nath J, Demarco T, Hourigan L, Heidenreich PA, Foster E.
    Echocardiography; 2005 May; 22(5):374-9. PubMed ID: 15901287
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia.
    Karimi M, Borzouee M, Mehrabani A, Cohan N.
    Eur J Haematol; 2009 Mar; 82(3):213-8. PubMed ID: 19077048
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of PDE-5 inhibitor tadalafil in pulmonary arterial hypertension.
    Bharani A, Patel A, Saraf J, Jain A, Mehrotra S, Lunia B.
    Indian Heart J; 2007 Mar; 59(4):323-8. PubMed ID: 19126937
    [Abstract] [Full Text] [Related]

  • 6. Comparative study of pulmonary circulation and myocardial function in patients with β-thalassemia intermedia with and without hydroxyurea, a case-control study.
    Amoozgar H, Farhani N, Khodadadi N, Karimi M, Cheriki S.
    Eur J Haematol; 2011 Jul; 87(1):61-7. PubMed ID: 21447009
    [Abstract] [Full Text] [Related]

  • 7. Right ventricular cardiomyopathy in beta-thalassaemia major.
    Hahalis G, Manolis AS, Apostolopoulos D, Alexopoulos D, Vagenakis AG, Zoumbos NC.
    Eur Heart J; 2002 Jan; 23(2):147-56. PubMed ID: 11785997
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of cilostazol on right heart function and pulmonary pressure.
    Sahin M, Alizade E, Pala S, Alici G, Ozkan B, Akgun T, Emiroglu Y, Demir S, Yazicioglu MV, Turkmen MM.
    Cardiovasc Ther; 2013 Dec; 31(6):e88-93. PubMed ID: 23911039
    [Abstract] [Full Text] [Related]

  • 11. A randomized pilot study on the effect of niacin on pulmonary arterial pressure.
    McNamara MJ, Sayanlar JJ, Dooley DJ, Srichai MB, Taylor AJ.
    Trials; 2015 Nov 21; 16():530. PubMed ID: 26590128
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Right ventricular myocardial isovolumic relaxation time as novel method for evaluation of pulmonary hypertension: correlation with endothelin-1 levels.
    Fahmy Elnoamany M, Abdelraouf Dawood A.
    J Am Soc Echocardiogr; 2007 May 21; 20(5):462-9. PubMed ID: 17484984
    [Abstract] [Full Text] [Related]

  • 14. Postoperative non-invasive assessment of pulmonary vascular resistance using Doppler echocardiography.
    Albers J, Ister D, Kayhan N, Vahl CF.
    Interact Cardiovasc Thorac Surg; 2011 Dec 21; 13(6):579-84. PubMed ID: 21729949
    [Abstract] [Full Text] [Related]

  • 15. Effect of phosphodiesterase-5 inhibition on SystEmic Right VEntricular size and function. A multicentre, double-blind, randomized, placebo-controlled trial: SERVE.
    Greutmann M, Tobler D, Engel R, Heg D, Mueller C, Frenk A, Gabriel H, Rutz T, Buechel RR, Willhelm M, Trachsel L, Freese M, Ruperti-Repilado FJ, Valsangiacomo Buechel E, Beitzke D, Haaf P, Wustmann K, Schwitz F, Possner M, Schwitter J, Bouchardy J, Schwerzmann M, SERVE Investigators.
    Eur J Heart Fail; 2023 Jul 21; 25(7):1105-1114. PubMed ID: 37264734
    [Abstract] [Full Text] [Related]

  • 16. Speckle-tracking-derived strain and strain-rate analysis: a technique for the evaluation of early alterations in right ventricle systolic function in patients with systemic sclerosis and normal pulmonary artery pressure.
    Matias C, Isla LP, Vasconcelos M, Almería C, Rodrigo JL, Serra V, Zamorano J.
    J Cardiovasc Med (Hagerstown); 2009 Feb 21; 10(2):129-34. PubMed ID: 19194173
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Functional tricuspid regurgitation in patients with pulmonary hypertension: is pulmonary artery pressure the only determinant of regurgitation severity?
    Mutlak D, Aronson D, Lessick J, Reisner SA, Dabbah S, Agmon Y.
    Chest; 2009 Jan 21; 135(1):115-121. PubMed ID: 18719061
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.